Morgan Stanley’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,541
| Closed | -$3.3K | – | 8038 |
|
|
2024
Q1 | $3.3K | Sell |
17,541
-17,541
| -50% | -$3.47K | ﹤0.01% | 6983 |
|
|
2023
Q4 | $7.08K | Buy |
35,082
+16,234
| +86% | +$6.36K | ﹤0.01% | 6918 |
|
|
2023
Q3 | $13.1K | Hold |
18,848
| – | – | ﹤0.01% | 6625 |
|
|
2023
Q2 | $16.7K | Sell |
18,848
-5,320
| -22% | -$4.51K | ﹤0.01% | 6625 |
|
|
2023
Q1 | $18.2K | Sell |
24,168
-103,709
| -81% | -$135K | ﹤0.01% | 6663 |
|
|
2022
Q4 | $147K | Sell |
127,877
-49,971
| -28% | -$41.3K | ﹤0.01% | 5795 |
|
|
2022
Q3 | $156K | Buy |
177,848
+112,082
| +170% | +$136K | ﹤0.01% | 5849 |
|
|
2022
Q2 | $73K | Sell |
65,766
-686,466
| -91% | -$589K | ﹤0.01% | 6428 |
|
|
2022
Q1 | $1.04M | Sell |
752,232
-229,303
| -23% | -$490K | ﹤0.01% | 4959 |
|
|
2021
Q4 | $3.35M | Buy |
981,535
+921,126
| +1,525% | +$5.19M | ﹤0.01% | 4141 |
|
|
2021
Q3 | $533K | Buy |
60,409
+39,712
| +192% | +$522K | ﹤0.01% | 5455 |
|
|
2021
Q2 | $352K | Buy |
20,697
+16,833
| +436% | +$246K | ﹤0.01% | 5724 |
|
|
2021
Q1 | $52K | Sell |
3,864
-5,143
| -57% | -$116K | ﹤0.01% | 6338 |
|
|
2020
Q4 | $259K | Buy |
9,007
+4,747
| +111% | +$128K | ﹤0.01% | 5457 |
|
|
2020
Q3 | $127K | Buy |
+4,260
| New | +$129K | ﹤0.01% | 5317 |
|
Other funds holding AFIB
Morgan Stanley's AFIB Position: Q2 2024 in Review
Morgan Stanley sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 17,541 shares — an estimated $3.3K sold.
Morgan Stanley first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $3.35M in Q4 2021. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- Morgan Stanley reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 17,541 Acutus Medical Inc shares in Q2 2024, an estimated $3.3K.
- Morgan Stanley first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
- Morgan Stanley's Acutus Medical Inc position peaked at $3.35M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.